KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Travere Therapeutics (TVTX) Tax Rate (2016 - 2025)

Travere Therapeutics (TVTX) has disclosed Tax Rate for 12 consecutive years, with 4.37% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Tax Rate fell 449.0% year-over-year to 4.37%, compared with a TTM value of 2.01% through Dec 2025, down 197.0%, and an annual FY2025 reading of 2.01%, down 197.0% over the prior year.
  • Tax Rate was 4.37% for Q4 2025 at Travere Therapeutics, down from 0.03% in the prior quarter.
  • Across five years, Tax Rate topped out at 0.15% in Q3 2024 and bottomed at 4.37% in Q4 2025.
  • Average Tax Rate over 5 years is 0.3%, with a median of 0.08% recorded in 2023.
  • The sharpest move saw Tax Rate tumbled -10503bps in 2021, then soared 52bps in 2022.
  • Year by year, Tax Rate stood at 0.0% in 2021, then tumbled by -1534bps to 0.07% in 2022, then decreased by -4bps to 0.08% in 2023, then surged by 255bps to 0.12% in 2024, then plummeted by -3764bps to 4.37% in 2025.
  • Business Quant data shows Tax Rate for TVTX at 4.37% in Q4 2025, 0.03% in Q3 2025, and 0.16% in Q2 2025.